CAS 494-19-9 Iminodibenzyl Pharmaceutical Raw Material

Name: CAS 494-19-9 Iminodibenzyl Pharmaceutical Raw Material
Brand: Xi'an Salis Biological Co., Ltd.
SKU: 2246366175

Shaanxi, ChinaXi'an Salis Biological Co., Ltd.

US$60.00-150.00

1 kg

Sample price:US$8.00/piece.Request sample

Product profile

Customization

Available

Powder

Yes

Customized

Non-Customized

Model NO.

salis250902612

Certification

GMP, ISO 9001

Suitable for

Adult

State

Solid

Purity

>99%

Age Group

Adults

Gender

Unisex

Product Type

API

Function

Health

Type

API

Logo Printing

OEM

Sample

Available

MOQ

10g

OEM Service

Available

Storage Method

Cool Dry Place

ODM

Available

Shelf

2 Years

Transport Package

Foil Bag

Specification

Extract

Trademark

OEM

Origin

China

Production Capacity

50000PCS

Company profile

OEM ServicesIn-stock CapacityQuality AssuranceR&D Capabilities

Xi'an Salis Biological Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 2 years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤5.58h

AI-Powered supplier vetting

SummaryThe supplier is a high-tech enterprise specializing in natural plant extracts and intermediates, with a focus on R&D, production, and sales. Despite its extensive production capacity and customization capabilities, the supplier lacks significant innovation in new product development and has no written procedures for after-sales service. Financially, the supplier reported no operating revenue or profit in recent years, which raises concerns about its financial credibility. The supplier does not hold any certifications, and has no overseas warehouse or showroom capabilities.

Supplier typeThe supplier is a high-tech enterprise focusing on R&D, production, processing, and sales of natural plant extracts and intermediates.

CertificationsThe supplier does not hold any certifications for its management systems.

After-Sales capabilityThere are no written procedures or records for after-sales service, indicating a lack of structured after-sales service capability.

Financial creditThe supplier reported no operating revenue or profit in the last two years, indicating a lack of financial credibility.

R&D capabilityThe supplier lacks significant R&D capability and has not introduced new products in the past year. No SDK availability further supports limited innovation.

Production capacityThe supplier has a significant annual production capacity of 300 tons each for Glutathione and Methionine, indicating robust production capabilities.

Customization capabilityThe supplier offers extensive customization options, including full, minor, and flexible customization services.